Summary
Rustagi AS, Kamineni A, Weinmann S, Reed SD, Newcomb P, Weiss NS. Cervical screening and cervical cancer death among older women: a population-based, case-control study. Am J Epidemiol. 2014;179(9):1107-1114.
Researchers in a case-control study sought to quantify the efficacy of cervical cytology screening to reduce death from cervical cancer by comparing Papanicolaou (PAP) test screening histories of women (aged 55-79 y) who died of cervical cancer between 1980 and 2010 (cases) to those of women at risk of cervical cancer (controls). Of these women, 80 eligible controls were matched 2:1 to 39 eligible cases based on health plan, age, and enrollment duration. After adjustment for matching characteristics, smoking, marital status, and race/ethnicity using logistic regression, the odds ratio of death from cervical cancer associated with screening was 0.26 (95% CI, 0.10-0.63). Researchers estimated that screening US women aged 55 to 79 years could avert 630 deaths annually.
The North American Menopause Society (NAMS) © 2014 The North American Menopause Society
